Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Therapies02:49

Cancer Therapies

7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety, tolerability, relative bioavailability, pharmacokinetics, and pharmacodynamics of single and multiple doses of the novel oral bofanglutide in healthy Chinese participants.

Diabetes research and clinical practice·2026
Same author

Extending prenatal perspectives: perinatal and neonatal physiological states in the early etiology of childhood ADHD.

European child & adolescent psychiatry·2026
Same author

TRIM22-mediated ubiquitin-dependent degradation of FLT3-ITD overcomes TKI resistance in acute myeloid leukemia.

Life medicine·2026
Same author

Explainable AI in Near-Infrared Spectroscopy: A Case Study of Rice Protein Content.

Journal of food science·2026
Same author

Structural Modification and Enhanced Gel Properties of Peanut Protein via Co-Precipitation with Egg White Protein.

Foods (Basel, Switzerland)·2026
Same author

Indocyanine green angiography and machine learning analysis determine topographic distribution of peripheral hard drusen in a Chinese cohort.

Communications medicine·2026

Related Experiment Video

Updated: Sep 11, 2025

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

9.9K

LncSNHGs: new targets in osteosarcoma.

Yining Zhang1,2, Jinfa Wu1,3, Jiaming Liu4,5

  • 1Department of Orthopaedic Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, PR China.

Cancer Gene Therapy
|August 16, 2025
PubMed
Summary

Long non-coding RNAs (lncRNAs) in small nucleolar RNA host genes (SNHGs) are crucial in osteosarcoma (OS) development. Dysregulated SNHG expression impacts tumor growth, metastasis, and treatment, offering new diagnostic and therapeutic targets for OS.

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.3K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.8K

Related Experiment Videos

Last Updated: Sep 11, 2025

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

9.9K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.3K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.8K

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Long non-coding RNAs (lncRNAs) are key regulators in cancer biology.
  • Osteosarcoma (OS) is a primary bone malignancy with complex genetic underpinnings.
  • Small nucleolar RNA host genes (SNHGs) are a lncRNA family implicated in various cancers.

Purpose of the Study:

  • To provide a comprehensive review of the lncRNA SNHG family in osteosarcoma.
  • To elucidate the biological roles and molecular mechanisms of SNHGs in OS.
  • To summarize expression patterns and clinical relevance of SNHGs in OS.

Main Methods:

  • Literature review and analysis of existing studies on SNHGs in osteosarcoma.
  • Examination of molecular mechanisms underlying SNHG functions in OS.
  • Synthesis of data on SNHG expression and its correlation with OS progression.

Main Results:

  • SNHG family members show altered expression in osteosarcoma tissues.
  • Dysregulated SNHGs influence critical oncogenic processes like proliferation, metastasis, and apoptosis.
  • SNHGs are implicated in chemoresistance and autophagy modulation in OS.

Conclusions:

  • The lncRNA SNHG family represents a significant area of research in osteosarcoma.
  • SNHGs play multifaceted roles in OS pathogenesis, affecting tumor growth and treatment response.
  • Targeting SNHGs may offer novel diagnostic, prognostic, and therapeutic strategies for osteosarcoma.